|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
|
0.850 |
GeneticVariation |
GWASCAT |
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
|
27117709 |
2016 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
|
0.850 |
GeneticVariation |
BEFREE |
Ten SNPs (rs2075555 in COL1A1, rs12652447 in FBXL17, rs10941679 in 5p12/MRPS30, rs11878583 in ZNF577, rs7166081 in SMAD3, rs16917302 in ZNF365, rs311499 in 20q13.3, rs1045485 in CASP8, rs12964873 in CDH1 and rs8170 in 19p13.1) were here genotyped in 1009 Chinese females (487 patients with breast cancer and 522 control subjects) using the Sequenom MassARRAY iPLEX platform.
|
24528085 |
2014 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
|
0.850 |
GeneticVariation |
BEFREE |
Seven SNPs were statistically significant (P ≤ 0.05) with the risk of overall breast cancer in the same direction as previously reported: rs10069690 (5p15/TERT), rs999737 (14q24/RAD51L1), rs13387042 (2q35/TNP1), rs1219648 (10q26/FGFR2), rs8170 (19p13/BABAM1), rs17817449 (16q12/FTO), and rs13329835 (16q23/DYL2).
|
23593120 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
A |
0.850 |
GeneticVariation |
GWASCAT |
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
|
23535733 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
G |
0.850 |
GeneticVariation |
GWASDB |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
G |
0.850 |
GeneticVariation |
GWASCAT |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.
|
23544013 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
|
0.850 |
GeneticVariation |
BEFREE |
Variants from 19p13.1 were not associated with breast cancer overall or with ER-positive breast cancer but were significantly associated with ER-negative breast cancer risk [rs8170 OR, 1.10; 95% confidence interval (CI), 1.05-1.15; P = 3.49 × 10(-5)] and triple-negative (ER-, PR-, and HER2-negative) breast cancer (rs8170: OR, 1.22; 95% CI, 1.13-1.31; P = 2.22 × 10(-7)).
|
22331459 |
2012 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
|
0.850 |
GeneticVariation |
BEFREE |
We confirmed associations between rs8170 at 19p13.1 and breast cancer risk for BRCA1 mutation carriers [HR, 1.17; 95% confidence interval (CI), 1.07-1.27; P = 7.42 × 10(-4)] and between rs16917302 at ZNF365 (HR, 0.84; 95% CI, 0.73-0.97; P = 0.017) but not rs311499 at 20q13.3 (HR, 1.11; 95% CI, 0.94-1.31; P = 0.22) and breast cancer risk for BRCA2 mutation carriers.
|
22351618 |
2012 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
|
0.850 |
GeneticVariation |
BEFREE |
Five SNPs on 19p13 were associated with breast cancer risk (P(trend) = 2.3 × 10⁻⁹ to P(trend) = 3.9 × 10⁻⁷), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89).
|
20852631 |
2010 |
|
rs8170
|
BABAM1;USHBP1
|
Breast Carcinoma
|
A |
0.850 |
GeneticVariation |
GWASCAT |
Five SNPs on 19p13 were associated with breast cancer risk (P(trend) = 2.3 × 10⁻⁹ to P(trend) = 3.9 × 10⁻⁷), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89).
|
20852631 |
2010 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
|
0.750 |
GeneticVariation |
BEFREE |
Ten SNPs (rs2075555 in COL1A1, rs12652447 in FBXL17, rs10941679 in 5p12/MRPS30, rs11878583 in ZNF577, rs7166081 in SMAD3, rs16917302 in ZNF365, rs311499 in 20q13.3, rs1045485 in CASP8, rs12964873 in CDH1 and rs8170 in 19p13.1) were here genotyped in 1009 Chinese females (487 patients with breast cancer and 522 control subjects) using the Sequenom MassARRAY iPLEX platform.
|
24528085 |
2014 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
|
0.750 |
GeneticVariation |
BEFREE |
Seven SNPs were statistically significant (P ≤ 0.05) with the risk of overall breast cancer in the same direction as previously reported: rs10069690 (5p15/TERT), rs999737 (14q24/RAD51L1), rs13387042 (2q35/TNP1), rs1219648 (10q26/FGFR2), rs8170 (19p13/BABAM1), rs17817449 (16q12/FTO), and rs13329835 (16q23/DYL2).
|
23593120 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
A |
0.750 |
GeneticVariation |
GWASDB |
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
|
23535733 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
|
0.750 |
GeneticVariation |
BEFREE |
We confirmed associations between rs8170 at 19p13.1 and breast cancer risk for BRCA1 mutation carriers [HR, 1.17; 95% confidence interval (CI), 1.07-1.27; P = 7.42 × 10(-4)] and between rs16917302 at ZNF365 (HR, 0.84; 95% CI, 0.73-0.97; P = 0.017) but not rs311499 at 20q13.3 (HR, 1.11; 95% CI, 0.94-1.31; P = 0.22) and breast cancer risk for BRCA2 mutation carriers.
|
22351618 |
2012 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
|
0.750 |
GeneticVariation |
BEFREE |
Variants from 19p13.1 were not associated with breast cancer overall or with ER-positive breast cancer but were significantly associated with ER-negative breast cancer risk [rs8170 OR, 1.10; 95% confidence interval (CI), 1.05-1.15; P = 3.49 × 10(-5)] and triple-negative (ER-, PR-, and HER2-negative) breast cancer (rs8170: OR, 1.22; 95% CI, 1.13-1.31; P = 2.22 × 10(-7)).
|
22331459 |
2012 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
A |
0.750 |
GeneticVariation |
GWASDB |
Five SNPs on 19p13 were associated with breast cancer risk (P(trend) = 2.3 × 10⁻⁹ to P(trend) = 3.9 × 10⁻⁷), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89).
|
20852631 |
2010 |
|
rs8170
|
BABAM1;USHBP1
|
Malignant neoplasm of breast
|
|
0.750 |
GeneticVariation |
BEFREE |
Five SNPs on 19p13 were associated with breast cancer risk (P(trend) = 2.3 × 10⁻⁹ to P(trend) = 3.9 × 10⁻⁷), two of which showed independent associations (rs8170, hazard ratio (HR) = 1.26, 95% CI 1.17-1.35; rs2363956 HR = 0.84, 95% CI 0.80-0.89).
|
20852631 |
2010 |
|
rs8170
|
BABAM1;USHBP1
|
Epithelial ovarian cancer
|
|
0.720 |
GeneticVariation |
BEFREE |
Common variant rs8170 and rare variants in ATG2B may be associated with EOC overall survival, although further study is needed.
|
26747452 |
2016 |
|
rs8170
|
BABAM1;USHBP1
|
Epithelial ovarian cancer
|
A |
0.720 |
GeneticVariation |
GWASCAT |
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
|
25581431 |
2015 |
|
rs8170
|
BABAM1;USHBP1
|
Epithelial ovarian cancer
|
|
0.720 |
GeneticVariation |
BEFREE |
Expression analysis of candidate genes at this locus in ovarian tumors supported a role for the BRCA1-interacting gene C19orf62, also known as MERIT40, which contains rs8170, in EOC development.
|
20852633 |
2010 |
|
rs8170
|
BABAM1;USHBP1
|
ovarian neoplasm
|
|
0.710 |
GeneticVariation |
GWASCAT |
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
|
23535730 |
2013 |
|
rs8170
|
BABAM1;USHBP1
|
ovarian neoplasm
|
|
0.710 |
GeneticVariation |
BEFREE |
Expression analysis of candidate genes at this locus in ovarian tumors supported a role for the BRCA1-interacting gene C19orf62, also known as MERIT40, which contains rs8170, in EOC development.
|
20852633 |
2010 |
|
rs4808075
|
BABAM1;USHBP1
|
Ovarian Serous Adenocarcinoma
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
|
rs4808075
|
BABAM1;USHBP1
|
ovarian neoplasm
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
|
28346442 |
2017 |
|
rs4808075
|
BABAM1;USHBP1
|
Prostate carcinoma
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
|
27197191 |
2016 |